Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001593610 | SCV001816693 | likely benign | not provided | 2020-12-22 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001593610 | SCV002440650 | benign | not provided | 2023-08-19 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004039503 | SCV002755430 | uncertain significance | not specified | 2018-01-31 | criteria provided, single submitter | clinical testing | The p.R1217H variant (also known as c.3650G>A), located in coding exon 2 of the KIAA2022 gene, results from a G to A substitution at nucleotide position 3650. The arginine at codon 1217 is replaced by histidine, an amino acid with highly similar properties. This amino acid position is well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |